These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 10379287)
1. The use of biodegradable polylactic acid barrier materials in the treatment of grade II periodontal furcation defects in humans--Part II: A multicenter investigative surgical study. Vernino AR; Wang HL; Rapley J; Nechamkin SJ; Ringeisen TA; Derhalli M; Brekke J Int J Periodontics Restorative Dent; 1999 Feb; 19(1):56-65. PubMed ID: 10379287 [TBL] [Abstract][Full Text] [Related]
2. Use of biodegradable polylactic acid barrier materials in the treatment of grade II periodontal furcation defects in humans--Part I: A multicenter investigative clinical study. Vernino AR; Ringeisen TA; Wang HL; Derhalli M; Rapley J; Nechamkin SJ; Brekke J Int J Periodontics Restorative Dent; 1998 Dec; 18(6):572-85. PubMed ID: 10321172 [TBL] [Abstract][Full Text] [Related]
3. Periodontal regeneration of a class II furcation defect utilizing a bioabsorbable barrier in a human. A case study with histology. Stoller NH; Johnson LR; Garrett S J Periodontol; 2001 Feb; 72(2):238-42. PubMed ID: 11288798 [TBL] [Abstract][Full Text] [Related]
4. Effects of expanded polytetrafluoroethylene and polylactic acid barriers on healthy sites. Trejo PM; Weltman R; Caffesse RG J Periodontol; 1998 Jan; 69(1):14-8. PubMed ID: 9527556 [TBL] [Abstract][Full Text] [Related]
5. A prospective multi-center study evaluating periodontal regeneration for Class II furcation invasions and intrabony defects after treatment with a bioabsorbable barrier membrane: 1-year results. Becker W; Becker BE; Mellonig J; Caffesse RG; Warrer K; Caton JG; Reid T J Periodontol; 1996 Jul; 67(7):641-9. PubMed ID: 8832474 [TBL] [Abstract][Full Text] [Related]
6. Guided tissue regeneration in human Class II furcation defects using a diphenylphosphorylazide-cross-linked collagen membrane: a consecutive case series. Zahedi CS; Miremadi SA; Brunel G; Rompen E; Bernard JP; Benque E J Periodontol; 2003 Jul; 74(7):1071-9. PubMed ID: 12931772 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of the treatment of class II furcation involvements with bioabsorbable barriers alone or associated with demineralized freeze-dried bone allografts. De Leonardis D; Garg AK; Pedrazzoli V; Pecora GE J Periodontol; 1999 Jan; 70(1):8-12. PubMed ID: 10052766 [TBL] [Abstract][Full Text] [Related]
8. Factors influencing the outcome of regenerative therapy in mandibular Class II furcations: Part I. Bowers GM; Schallhorn RG; McClain PK; Morrison GM; Morgan R; Reynolds MA J Periodontol; 2003 Sep; 74(9):1255-68. PubMed ID: 14584858 [TBL] [Abstract][Full Text] [Related]
9. Comparison of bioabsorbable laminar bone membrane and non-resorbable ePTFE membrane in mandibular furcations. Scott TA; Towle HJ; Assad DA; Nicoll BK J Periodontol; 1997 Jul; 68(7):679-86. PubMed ID: 9249640 [TBL] [Abstract][Full Text] [Related]
10. Clinical comparison of microporous biocompatible composite of PMMA, PHEMA and calcium hydroxide grafts and expanded polytetrafluoroethylene barrier membranes in human mandibular molar Class II furcations. A case series. Calongne KB; Aichelmann-Reidy ME; Yukna RA; Mayer ET J Periodontol; 2001 Oct; 72(10):1451-9. PubMed ID: 11699489 [TBL] [Abstract][Full Text] [Related]
11. Comparison of a bioabsorbable GTR barrier to a non-absorbable barrier in treating human class II furcation defects. A multi-center parallel design randomized single-blind trial. Garrett S; Polson AM; Stoller NH; Drisko CL; Caton JG; Harrold CQ; Bogle G; Greenwell H; Lowenguth RA; Duke SP; DeRouen TA J Periodontol; 1997 Jul; 68(7):667-75. PubMed ID: 9249638 [TBL] [Abstract][Full Text] [Related]
12. Clinical comparison of bioabsorbable barriers with non-resorbable barriers in guided tissue regeneration in the treatment of human intrabony defects. Teparat T; Solt CW; Claman LJ; Beck FM J Periodontol; 1998 Jun; 69(6):632-41. PubMed ID: 9660331 [TBL] [Abstract][Full Text] [Related]
13. Factors influencing treatment outcomes in mandibular Class II furcation defects. Tsao YP; Neiva R; Al-Shammari K; Oh TJ; Wang HL J Periodontol; 2006 Apr; 77(4):641-6. PubMed ID: 16584345 [TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial comparing enamel matrix derivative and membrane treatment of buccal class II furcation involvement in mandibular molars. Part II: secondary outcomes. Meyle J; Gonzales JR; Bödeker RH; Hoffmann T; Richter S; Heinz B; Arjomand M; Reich E; Sculean A; Jepsen K; Jepsen S J Periodontol; 2004 Sep; 75(9):1188-95. PubMed ID: 15515332 [TBL] [Abstract][Full Text] [Related]
15. The use of 2 bioabsorbable barrier membranes in the treatment of interproximal intrabony periodontal defects. Mattson JS; Gallagher SJ; Jabro MH J Periodontol; 1999 May; 70(5):510-7. PubMed ID: 10368055 [TBL] [Abstract][Full Text] [Related]
16. Treatment of human class II furcation defects using connective tissue grafts, bioabsorbable membrane, and resorbable hydroxylapatite: a comparative study. Belal MH; Al-Noamany FA; El-Tonsy MM; El-Guindy HM; Ishikawa I J Int Acad Periodontol; 2005 Oct; 7(4):114-28. PubMed ID: 16245642 [TBL] [Abstract][Full Text] [Related]
17. Periodontal regeneration in naturally occurring Class II furcation defects in beagle dogs after guided tissue regeneration with bioabsorbable barriers. Bogle G; Garrett S; Stoller NH; Swanbom DD; Fulfs JC; Rodgers PW; Whitman S; Dunn RL; Southard GL; Polson AM J Periodontol; 1997 Jun; 68(6):536-44. PubMed ID: 9203097 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of guided tissue regeneration procedure in the treatment of grade II mandibular molar furcations. Prathibha PK; Faizuddin M; Pradeep AR Indian J Dent Res; 2002; 13(1):37-47. PubMed ID: 12420567 [TBL] [Abstract][Full Text] [Related]
20. Treatment of class II furcation involvements in humans with bioresorbable and nonresorbable guided tissue regeneration barriers. A randomized multi-center study. Hugoson A; Ravald N; Fornell J; Johard G; Teiwik A; Gottlow J J Periodontol; 1995 Jul; 66(7):624-34. PubMed ID: 7562355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]